Flatulence https://greenmedinfo.com/taxonomy/term/2139/all en Flatus https://greenmedinfo.com/disease/flatus <div class="field field-image"> <div class="field-items"> <div class="field-item odd"> <img class="imagefield imagefield-field_image" width="450" height="450" alt="" src="//cdn.greenmedinfo.com/sites/default/files/Fart_0.jpg?1476222930" /> </div> </div> </div> <div class="field field-copyright"> <div class="field-items"> <div class="field-item odd"> Copyright: &lt;a href=&#039;http://www.123rf.com/profile_ahasoft2000&#039;&gt;ahasoft2000 / 123RF Stock Photo&lt;/a&gt; </div> </div> </div> <fieldset class="fieldgroup group-facebook-like-info"><legend>Facebook Like Info</legend><div class="field field-facebook-total-count"> <div class="field-items"> <div class="field-item odd"> 0 </div> </div> </div> </fieldset> Flatulence Tue, 14 Apr 2009 07:18:06 +0000 greenmedinfo 20049 at https://greenmedinfo.com Supplementation with a mixture of beta-glucan, inositol, and digestive enzymes reduces bloating, flatulence and abdominal pain, and improves the overall clinical condition of IBD-IBS patients. https://greenmedinfo.com/article/supplementation-mixture-beta-glucan-inositol-and-digestive-enzymes-reduces-blo PMID:  Eur Rev Med Pharmacol Sci. 2017 06 ;21(2 Suppl):102-107. PMID: 28724171 Abstract Title:  Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. Abstract:  OBJECTIVE: To evaluate the efficacy of a mixture of beta-glucan, inositol and digestive enzymes in improving gastrointestinal symptoms in patients affected by inflammatory bowel disease (IBD)-irritable bowel syndrome (IBS).PATIENTS AND METHODS: The study was conducted at the IBD Unit of the University of Catanzaro. Forty-three IBD patients with IBS symptoms were included in the study. IBD diagnosis was performed by clinical, endoscopic, histological and radiological criteria. Patients were in clinical remission and in treatment only with systemical and topical mesalamine. All study participants fulfilled the Rome III criteria for the diagnosis of IBS. The study participants were randomized into 2 groups: group A (n=23) received conventional treatment (systemical and topical mesalamine) plus a mixture of beta-glucan, inositol and digestive enzymes (one tablet after lunch and dinner) for four consecutive weeks; group B (n=20) received only conventional treatment. The prevalence and intensity of gastrointestinal (GI) symptoms were evaluated both at the enrollment (T0) and after four weeks of treatment (T1).RESULTS: Patients who received mesalamine plus the mixture of beta-glucan, inositol and digestive enzymes (group A) reported a reduction in abdominal pain together with reduction in bloating and flatulence after four weeks of treatment. Importantly, an overall improvement in the general well-being has been recorded. Patients who underwent only mesalamine treatment (group B) reported a mild reduction in the evacuative urgency without any other improvements.CONCLUSIONS: We have shown that supplementation with a mixture of beta-glucan, inositol and digestive enzymes reduces bloating, flatulence and abdominal pain, improving the overall clinical condition of IBD-IBS patients. <p><a href="https://greenmedinfo.com/article/supplementation-mixture-beta-glucan-inositol-and-digestive-enzymes-reduces-blo" target="_blank">read more</a></p> https://greenmedinfo.com/article/supplementation-mixture-beta-glucan-inositol-and-digestive-enzymes-reduces-blo#comments Beta-glucan Bloating Flatulence Inflammatory Bowel Diseases Inositol Irritable Bowel Syndrome Human Study Thu, 27 Feb 2020 21:37:53 +0000 greenmedinfo 214237 at https://greenmedinfo.com